Lifestyle and Therapeutic Interventions for Metabolic Dysfunction–Associated Steatotic Liver Disease: An Overview and Update Spanning Pediatric and Adult Populations
Nov
2026
Description
Topic experts provide a review and discussion of lifestyle and therapeutic interventions for adult and pediatric patients with metabolic dysfunction–associated steatotic liver disease (MASLD) to avoid hepatic fibrosis progression. Presenters discuss the effectiveness of these interventions in isolation and in combination.
Presentations
1:00 PM
- 1:15 PM
Convention Center - Summit 3, The Park @TLM, Hall D
How to Manage an Adult Patient With Metabolic Dysfunction–Associated Steatotic Liver Disease and No Liver Fibrosis
Naim Alkhouri, MD, FAASLD | Presenter
1:15 PM
- 1:30 PM
Convention Center - Summit 3, The Park @TLM, Hall D
How to Manage an Adult Patient With Metabolic Dysfunction–Associated Steatotic Liver Disease and Advanced Liver Fibrosis
Monica A Tincopa, MD MSc | Presenter
1:30 PM
- 1:45 PM
Convention Center - Summit 3, The Park @TLM, Hall D
How to Manage a Pediatric Patient With Metabolic Dysfunction–Associated Steatotic Liver Disease
Emily R Perito, MD, MA | Presenter
